NAPROXEN News
NAPROXEN currently has 0 news articles, with 24 predicted indications.
This page combines the AI-predicted indications for NAPROXEN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (24):
- myositis (99.0%)
- bursitis (99.0%)
- arthropathy (99.0%)
- periarthritis (99.0%)
- spondyloarthropathy (99.0%)
- juvenile arthritis due to defect in LACC1 (99.0%)
- migraine disorder (99.0%)
- spondyloarthropathy, susceptibility to (99.0%)
- migraine with or without aura, susceptibility to (99.0%)
- osteoarthritis susceptibility (99.0%)
- osteoarthritis (99.0%)
- exostosis (99.0%)
- common cold (99.0%)
- fibromyalgia (99.0%)
- ankylosing spondylitis (99.0%)
- gout (99.0%)
- tendinitis (99.0%)
- headache disorder (99.0%)
- rheumatoid arthritis (99.0%)
- juvenile idiopathic arthritis (99.0%)
- brachydactyly-syndactyly syndrome (99.3%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (99.2%)
- acromesomelic dysplasia, Hunter-Thompson type (99.2%)
- brachyolmia-amelogenesis imperfecta syndrome (99.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.